UPDATE: Citi Upgrades Emerson (EMR) to Neutral
Tweet
Share
E-mail
Get Alerts EMR Hot Sheet
Price: $163.17 -0.29%
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
26 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
(Updated - January 14, 2019 9:41 AM EST)
(updated to correct rating action)
Citi analyst Andrew Kaplowitz upgraded Emerson (NYSE: EMR) from Sell to Neutral with a price target of $66.00 (from $69.00).
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $62.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- Johnson Rice Upgrades Core Laboratories (CLB) to Buy
- Wells Fargo Upgrades FOX Corp. (FOXA) to Overweight
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
